BiotechTube
Home/Rithim Biologics/J. Kevin Donahue, M.D.
JK

J. Kevin Donahue, M.D.

Co-founder, Director

Rithim Biologics

Therapeutic Areas

CardiovascularCardiac Arrhythmias

Rithim Biologics Pipeline

DrugIndicationPhase
Gene Therapy for Atrial TachyarrhythmiasFast heart rates originating in the atria (e.g., Atrial Fibrillation)Pre-clinical
Gene Therapy for Ventricular TachyarrhythmiasFast heart rates originating in the ventriclesPre-clinical

Leadership Team at Rithim Biologics

RL
Ronald L. Anderson
Co-Founder, President, Chief Executive Officer, Chairman of the Board
View full Rithim Biologics profile